PubMed

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation.

Hayden MR, Tyagi SC.

Nutr J. 2004 May 10;3:4.PMID: 15134582 [PubMed]Related articlesFree article

Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.

Hayden MR, Tyagi SC.

Cardiovasc Diabetol. 2003 Feb 12;2:2.PMID: 12628022 [PubMed]Related articlesFree article

Homocysteine as a risk factor for cardiovascular and related disease: nutritional implications.

Weir DG, Scott JM.

Nutr Res Rev. 1998 Dec;11(2):311-38.PMID: 19094252 [PubMed - in process]Related articles

Folate, homocysteine, endothelial function and cardiovascular disease.

Moat SJ, Lang D, McDowell IF, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J.

J Nutr Biochem. 2004 Feb;15(2):64-79. Review.PMID: 14972346 [PubMed - indexed for MEDLINE]Related articles

Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.

Dinleyici EC, Kirel B, Alatas O, Muslumanoglu H, Kilic Z, Dogruel N.

J Trop Pediatr. 2006 Aug;52(4):260-6. Epub 2006 Jan 9.PMID: 16401615 [PubMed - indexed for MEDLINE]Related articles

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Hayden MR, Tyagi SC.

Nutr Metab (Lond). 2004 Oct 19;1(1):10.PMID: 15507132 [PubMed - as supplied by publisher]Related articlesFree article

Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?

Shargorodsky M, Boaz M, Pasternak S, Hanah R, Matas Z, Fux A, Beigel Y, Mashavi M.

Diabetes Metab Res Rev. 2009 Jan;25(1):70-5.PMID: 19065546 [PubMed - indexed for MEDLINE]Related articles

Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.

de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E.

J Diabetes Complications. 2005 Jan-Feb;19(1):42-6.PMID: 15642489 [PubMed - indexed for MEDLINE]Related articles

Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.

Russo GT, Di Benedetto A, Alessi E, Ientile R, Antico A, Nicocia G, La Scala R, Di Cesare E, Raimondo G, Cucinotta D.

J Endocrinol Invest. 2006 Mar;29(3):201-7.PMID: 16682831 [PubMed - indexed for MEDLINE]Related articles

Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population.

Huerta JM, González S, Vigil E, Prada M, San Martín J, Fernández S, Patterson AM, Lasheras C.

Clin Biochem. 2004 Oct;37(10):904-10.PMID: 15369722 [PubMed - indexed for MEDLINE]Related articles

Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.

Herrmann W, Schorr H, Obeid R, Makowski J, Fowler B, Kuhlmann MK.

Clin Chem. 2005 May;51(5):891-7. Epub 2005 Mar 17.PMID: 15774574 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.PMID: 15252738 [PubMed - indexed for MEDLINE]Related articles

Homocysteine and B vitamins.

Cook S, Hess OM.

Handb Exp Pharmacol. 2005;(170):325-38. Review.PMID: 16596805 [PubMed - indexed for MEDLINE]Related articles

Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).

Shenoy KT, Lena KB, Sali N, Syam S, Shenoy ST, Rajadhyaksha VD, Pai GP, Shaikh AA; Cardiovit Study Team.

Curr Med Res Opin. 2006 Apr;22(4):641-8.PMID: 16684424 [PubMed - indexed for MEDLINE]Related articles

Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.

Wolters M, Hermann S, Hahn A.

Eur J Nutr. 2005 Mar;44(3):183-92. Epub 2004 May 19.PMID: 15309436 [PubMed - indexed for MEDLINE]Related articles

Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation.

Hayden MR, Tyagi SC.

Cardiovasc Diabetol. 2004 Feb 4;3:1.PMID: 14761253 [PubMed]Related articlesFree article

Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.

Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G.

Atherosclerosis. 2006 Nov;189(1):236-40. Epub 2006 Jan 18.PMID: 16414052 [PubMed - indexed for MEDLINE]Related articles

B-vitamins and homocysteine in Spanish institutionalized elderly.

Gonzalez-Gross M, Sola R, Albers U, Barrios L, Alder M, Castillo MJ, Pietrzik K.

Int J Vitam Nutr Res. 2007 Jan;77(1):22-33.PMID: 17685092 [PubMed - indexed for MEDLINE]Related articles

Homocysteine-lowering treatment in coronary heart disease.

Cesari M, Rossi GP, Pessina AC.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Oct;3(4):289-95. Review.PMID: 16250860 [PubMed - indexed for MEDLINE]Related articles

Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors.

Diakoumopoulou E, Tentolouris N, Kirlaki E, Perrea D, Kitsou E, Psallas M, Doulgerakis D, Katsilambros N.

Nutr Metab Cardiovasc Dis. 2005 Apr;15(2):109-17. Epub 2005 Apr 13.PMID: 15871859 [PubMed - indexed for MEDLINE]Related articles